Correlation Between Viridian Therapeutics and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Viridian Therapeutics and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Vertex Pharmaceuticals.
Diversification Opportunities for Viridian Therapeutics and Vertex Pharmaceuticals
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Viridian and Vertex is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Vertex Pharmaceuticals
Given the investment horizon of 90 days Viridian Therapeutics is expected to under-perform the Vertex Pharmaceuticals. In addition to that, Viridian Therapeutics is 2.71 times more volatile than Vertex Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.07 per unit of volatility. If you would invest 29,392 in Vertex Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 17,530 from holding Vertex Pharmaceuticals or generate 59.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Viridian Therapeutics |
| Vertex Pharmaceuticals |
Viridian Therapeutics and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Vertex Pharmaceuticals
The main advantage of trading using opposite Viridian Therapeutics and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |